Baylor Genetics Partners With Rainbow Genomics Offering Adult Wellness Screening And High-Risk Cancer Exome Sequencing Tests In Asian Pacific
Published: Sep 26, 2017
HONG KONG and HOUSTON, Sept. 25, 2017 /PRNewswire/ -- Baylor Genetics announces a partnership with Hong Kong-based Rainbow Genomics to provide clinical whole exome sequencing tests to patients in Hong Kong, Japan, Singapore and other Asian countries. Product offering includes adult exome screening, high-risk cancer and wellness cancer tests.
Unlike many "recreational" consumer genetic tests currently available in Asia, these are medical evidence-based genetic tests designed to help physicians screen, diagnose and manage genetic disorders. Plus, these are exome-sequencing-based tests, covering over 22,000 genes, which may increase diagnostic yield, and include genes that may be more specific to Asians.
To overcome the significant shortage of certified genetic counselors in the region, Rainbow Genomics works closely with the Consultagene services from Baylor College of Medicine, to deliver bilingual genetic counseling to patients in English, Mandarin, Cantonese and Japanese. Peer-to-peer consultation is also included to support local physicians to adopt "genetics" in their clinical practices.
"Baylor Genetics is enthusiastic about this partnership with Rainbow Genomics as it gives us the opportunity to serve a new patient population with our cutting-edge analysis and interpretation of genomic sequence," said Dr. Christine Eng, Chief Medical Officer of Baylor Genetics.
"Rainbow Genomics is committed to bringing validated genetic tests supported by clear medical evidence to patients and physicians in local communities," said Daniel Siu, CEO of Rainbow Genomics. "By partnering with Baylor Genetics, we are the first company to deliver whole exome sequencing tests coupled with highly-credible and experienced clinical interpretation from a leading U.S. medical Institution. Patients now have an affordable option to access precision medicine, and may finally obtain diagnoses on genetic disorders that have affected their families for years."
About Baylor Genetics
Baylor Genetics, an affiliate of the #1 NIH-funded genetics program at Baylor College of Medicine, has been a pioneer of precision medicine for nearly 40 years. Today, we offer a full spectrum of cost-effective genetic testing with clinically relevant solutions, access to world-renowned experts, and the confidence to provide patients with answers. Baylor Genetics, located in Houston's Texas Medical Center, serves clients in 50 states and 16 countries.
Baylor Genetics, located in Houston's Texas Medical Center, serves clients in 50 states and 16 countries. Connect with us via our website (bmgl.com), Twitter (@baylorgenetics), Facebook (facebook.com/baylorgenetics), or LinkedIn (linkedin.com/company/baylorgenetics).
About Rainbow Genomics
Rainbow Genomics is committed to providing clinically-validated and affordable genetic tests to patients in Hong Kong, Japan, Singapore and other Asian countries. The company delivers clinical interpretations specifically for Asians, based on expert understanding of their genetics, and medical care experience in Hong Kong, Japan, and the United States. Rainbow Genomics specializes in providing whole exome sequencing and pharmacogenomic tests to enable physicians to use genomic information for diagnosis, treatment, and disease prevention. Visit us at rainbowgenomics.com.
Senior Director, Brand Strategy
Daniel C. Siu
CEO, Rainbow Genomics
View original content with multimedia:http://www.prnewswire.com/news-releases/baylor-genetics-partners-with-rainbow-genomics-offering-adult-wellness-screening-and-high-risk-cancer-exome-sequencing-tests-in-asian-pacific-300525164.html
SOURCE Baylor Genetics